• user warning: Table './fnndrupaldev/term_node' is marked as crashed and last (automatic?) repair failed query: SELECT t.* FROM term_node r INNER JOIN term_data t ON r.tid = t.tid INNER JOIN vocabulary v ON t.vid = v.vid WHERE r.vid = 431705 ORDER BY v.weight, t.weight, t.name in /var/www/www.fnno.com/htdocs/modules/taxonomy/taxonomy.module on line 617.
  • user warning: Table './fnndrupaldev/sessions' is marked as crashed and last (automatic?) repair failed query: SELECT COUNT(sid) AS count FROM sessions WHERE timestamp >= 1419267097 AND uid = 0 in /var/www/www.fnno.com/htdocs/includes/session.inc on line 111.
  • user warning: Table './fnndrupaldev/sessions' is marked as crashed and last (automatic?) repair failed query: SELECT DISTINCT u.uid, u.name, s.timestamp FROM users u INNER JOIN sessions s ON u.uid = s.uid WHERE s.timestamp >= 1419267097 AND s.uid > 0 ORDER BY s.timestamp DESC in /var/www/www.fnno.com/htdocs/modules/user/user.module on line 765.

Watch for Shares of Amgen (AMGN) to Approach Resistance at $88.12

Published on Tue, 01/29/2013 - 13:37
By Peter Chu

Amgen (NASDAQ:AMGN) has opened bullishly above the pivot of $84.84 today and has reached the first level of resistance at $86.85. Investors may be interested in a cross of the next upside pivot targets of $88.12 and $91.40.

In the past 52 weeks, Amgen share prices have been bracketed by a low of $65.37 and a high of $90.81 and are now at $87.29, 34% above that low price. Over the last five market days, the 200-day moving average (MA) has gone up 0.3% while the 50-day MA has remained constant.

Amgen Inc. discovers, develops, manufactures, and markets human therapeutics based on cellular and molecular biology. The Company focuses its research on secreted protein and small molecule therapeutics, with particular emphasis on neuroscience and cancer. Amgen concentrates on the areas of hematology, cancer, infectious disease, endocrinology, neurobiology, and inflammation.

Amgen (NASDAQ:AMGN) has potential upside of 7.8% based on a current price of $87.29 and analysts' consensus price target of $94.10. The stock should find initial support at its 50-day moving average (MA) of $87.01 and further support at its 200-day MA of $80.21.

By Peter Chu
pchu@fnno.com

Latest News from FNNO

Bullish Moving Average Cross by Amazon.c...

Amazon.com (NASDAQ:AMZN) crossed over its 10-day moving average of $303.54 on a volume ...

American Vanguard Ranks the Highest in T...

Below are the three companies in the Fertilizers & Agricultural Chemicals industry with ...

Rockwell Medical Technologies Makes a Mo...

Up 2.6% to $8.54, Rockwell Medical Technologies (NASDAQ:RMTI), is one of today's notabl ...

Google Crosses Above its 10-day MA (GOOG...

Today, shares of Google (NASDAQ:GOOG) have advanced above their 10-day MA of $516.87 on ...

Nuance Communications has the Highest De...

Below are the three companies in the Application Software industry with the highest deb ...

Buyers Accumulate Shares of Town Sports ...

Town Sports International (NASDAQ:CLUB) is a company whose shares are active, trading 2 ...

Spartan Stores has the Highest Debt to E...

Below are the three companies in the Food Distributors industry with the highest debt t ...

Shares of Consol Energy Under Pressure, ...

One of today's notable stocks in decline is Consol Energy (NYSE:CNX), down 2.6% to $33. ...